| __timestamp | CymaBay Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 8185000 | 1802274 |
| Thursday, January 1, 2015 | 8871000 | 2512761 |
| Friday, January 1, 2016 | 9645000 | 2894488 |
| Sunday, January 1, 2017 | 12387000 | 8096274 |
| Monday, January 1, 2018 | 14381000 | 7985229 |
| Tuesday, January 1, 2019 | 19238000 | 8994597 |
| Wednesday, January 1, 2020 | 17425000 | 29772000 |
| Friday, January 1, 2021 | 23040000 | 33907000 |
| Saturday, January 1, 2022 | 25116000 | 26579000 |
| Sunday, January 1, 2023 | 51953000 | 49868547 |
In pursuit of knowledge
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Verona Pharma plc and CymaBay Therapeutics, Inc. have demonstrated distinct spending trajectories. From 2014 to 2023, CymaBay's SG&A expenses surged by over 530%, peaking in 2023. Meanwhile, Verona Pharma's spending increased by a staggering 2,670% during the same period, reflecting a strategic pivot in their operational focus. Notably, both companies saw their highest expenditures in 2023, with Verona Pharma's expenses reaching nearly 50 million, closely trailing CymaBay's 52 million. This trend underscores the growing emphasis on administrative efficiency and market positioning in the biotech sector. As these companies continue to innovate, their SG&A strategies will likely play a pivotal role in shaping their competitive edge.
Biogen Inc. vs CymaBay Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Viatris Inc. or CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
Walgreens Boots Alliance, Inc. vs Verona Pharma plc: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs CymaBay Therapeutics, Inc.
Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Verona Pharma plc or Novavax, Inc.
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
CymaBay Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Xencor, Inc.